Valneva Austria competitive analysis

Explore patent oppositions filed by Valneva Austria against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
Immunogenic CompositionGLAXOSMITHKLINE BIOLOGICALS SAJul 25, 2024
Immunogenic CompositionGLAXOSMITHKLINE BIOLOGICALS SAMar 16, 2020
Immunogenic CompositionGLAXOSMITHKLINE BIOLOGICALS SAAug 29, 2017

Explore Valneva Austria's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 24, 2024Aluminium Compounds For Use In Therapeutics And Vaccines1
Feb 22, 2023Zika Virus Vaccine1
Sep 14, 2022Aluminium Compounds For Use In Therapeutics And Vaccines1
Aug 10, 2022Isolated Polypeptide Of The Toxin A And Toxin B Proteins Of C. Difficile And Uses Thereof1
Oct 11, 2017Aluminium Compounds For Use In Therapeutics And Vaccines1

Latest PTAB cases involving Valneva Austria

Discover the latest PTAB cases involving Valneva Austria, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 6, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Valneva Austria

IPR2025-00776Mar 31, 2025VALNEVA AUSTRIATAKEDA VACCINESTerminated-Settled
IPR2023-00354Dec 27, 2022TAKEDA VACCINESVALNEVA AUSTRIAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Valneva Austria with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VALNEVA AUSTRIA3511
GLAXOSMITHKLINE BIOLOGICALS SA2910129
MAIWALD PATENTANWALTS169 - - -
TAKEDA VACCINES - 211